In today's Just The Facts..
archTIS has deployed its NC Protect software into the U.S. Department of Defense’s Microsoft DoD365 production environment. The company has also renewed 1,000 licences and says discussions toward a large-scale enterprise agreement are now back on track.
Critical Resources has completed its first drilling program at the Cap Burn Gold Project in New Zealand. 11 reverse-circulation holes tested mineralisation beneath a large soil anomaly, marking a low-impact first pass across a one-kilometre strike zone.
Telix Pharmaceuticals has delivered an update on its precision medicine portfolio, including lead imaging product, Illuccix, which has received regulatory approval in multiple global markets. The company also confirmed progress toward FDA resubmissions for two additional diagnostic imaging candidates.
Dimerix says BioMarin will acquire its U.S. partner Amicus Therapeutics in a US$4.8-billion deal. The transaction preserves Dimerix’s U.S. licensing agreement, including eligibility for milestones and royalties tied to its Phase 3 kidney drug.
#NCProtect #CyberSecurity #DepartmentOfDefense #CriticalResources #GoldExploration #NewZealandMining #TelixPharmaceuticals #PrecisionMedicine #Illuccix #FDAApproval #Dimerix #BioMarin #AmicusTherapeutics #KidneyDisease #BiotechNews #ASXStocks #InvestorUpdates #PharmaNews #MiningNews